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Vena cava superior syndrome related to right heart invasion of an unresectable 
hepatocellular carcinoma 
 
Case presentation 
A 75-year-old man with a history of alcoholic liver cirrhosis and hepatocellular carcinoma 
presented with a deterioration of his general condition, associated with clinical signs of vena 
cava superior syndrome: swollen and painful face and dilated subcutaneous jugular veins. The 
carcinoma was earlier diagnosed by cross-sectional imaging, confirmed by laboratory analysis 
and biopsy, and already consecutively treated for 8 years by respectively surgical right 
hepatectomy, radio-frequency ablation, chemoembolization with and without drug-eluting 
beads, and with catheter-directed yttrium-90 radioembolization. Axial (Fig. A) and 
reconstructed sagittal (Fig. B) contrast-enhanced computed tomography (CT) images revealed 
a large, enhancing tumor mass lesion (large arrows), originating from the left liver lobe and 
extending into the right atrium up to the right ventricle; extension of the tumor was also 
identified into the inferior vena cava (small arrow). Transthoracic echocardiography (Fig. C) 
confirmed a slightly hyperdense mass lesion (white arrows) protruding into the right atrium 
(RA) and right ventricle (RV); the left atrium (LA) and left ventricle (LV) were both tumor 
free. Based on these 2 independent imaging modalities, it was clear that the hepatocellular 
carcinoma grew not only from the left liver lobe into the inferior vena cava, but also into the 
right atrium and ventricle. It thereby obliterated nearly completely the right heart cavities, 
obstructed the drainage of vena cava superior, and was subsequently also associated with a 
vena cava superior syndrome. 
Discussion 
Hepatocellular carcinoma-related venous and atrial involvement is rare and mainly occurs as 
end-stage disease (1). Clinical symptoms are mainly swollen lower extremities and Budd-
Chiari syndrome, including ascites, abdominal pain and hepatomegaly. Vena cava superior 
syndrome might occur and is mostly associated with widespread hepatocellular carcinoma 
metastatic to mediastinal lymph nodes, thereby narrowing or occluding the superior vena cava 
(2). Treatment options are very limited and include radical surgical resection in very rare 
cases (3), palliative interventional stent implantation (2) or more frequently, best supportive, 
palliative care. In this case it was obvious that surgery was not an option. Transatrial stent 
placement, potentially effective in cases of cavo-atrial involvement, would not have been 
effective as well, as in this case the tumor extended into the right ventricle. Therefore, the 
patient was treated with best supportive care and died a few weeks later.  
In conclusion, a rare case of hepatocellular tumor extension in the right heart with vena cava 
superior syndrome as end stage disease, was clearly documented by CT and transthoracic 
echocardiography.  
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